# A Study to Evaluate the Performance, and Usability of TruPlex HIV/HepB/Syphilis Rapid Test

> **NCT07569913** · NA · NOT_YET_RECRUITING · sponsor: **bioLytical Laboratories** · enrollment: 500 (estimated)

## Conditions studied

- HIV1 Infection
- HIV 2 Infection
- Syphilis Infection
- Hepatitis B Infection

## Interventions

- **DEVICE:** TruPlex HIV/HepB/Syphilis Rapid Test

## Key facts

- **NCT ID:** NCT07569913
- **Lead sponsor:** bioLytical Laboratories
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-09-01
- **Primary completion:** 2027-01-01
- **Final completion:** 2027-06-01
- **Target enrollment:** 500 (ESTIMATED)
- **Last updated:** 2026-05-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07569913

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07569913, "A Study to Evaluate the Performance, and Usability of TruPlex HIV/HepB/Syphilis Rapid Test". Retrieved via AI Analytics 2026-06-22 from https://api.ai-analytics.org/clinical/NCT07569913. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*